Newborn Hearing Screening: Analysing the Effectiveness of Early Detection of Neonatal Hearing Loss in a Hospital in Greece.
efficacy
hearing loss
newborn hearing screening
newborns
transient evoked otoacoustic emissions
Journal
Cureus
ISSN: 2168-8184
Titre abrégé: Cureus
Pays: United States
ID NLM: 101596737
Informations de publication
Date de publication:
Nov 2021
Nov 2021
Historique:
accepted:
22
11
2021
entrez:
27
12
2021
pubmed:
28
12
2021
medline:
28
12
2021
Statut:
epublish
Résumé
Introduction The introduction of newborn hearing screening programs (NHSP) has drastically contributed to the early diagnosis of hearing loss (HL) in children, with the prospect of children developing speech as early as possible. This retrospective study aims to present and discuss the preliminary results of the NHSP at the University Hospital of Patras, Greece, highlighting the strengths and weaknesses of the program. The evaluation of the implementation of NHSP is important to confirm the effectiveness of the process and elaborate system failures. Materials The study describes the results of previous data collected from the NHSP in the Rio hospital of Patra and analyzed the conditions of the sample collected. The random sample involved newborns born between November 2018 - December 2020 at the University Hospital in Patra, Greece, which was assessed using transient evoked otoacoustic emissions (TEOAEs). Testing was performed twice per week on Thursday and Friday with a random sample, specifically examining the babies in the hospital these days. From the 2014 newborns assessed, 1491 were healthy neonates, while the other 523 required hospitalization in the neonatal unit. Results In total, there were 2014 live births; 1491 healthy neonates were screened with TEOAEs. Of them, 44 did not pass the first test. After retesting one month later, 31 passed the test, while the other 13 were referred to a hearing centre for further audiological testing with auditory brainstem response (ABR) tests. Two infants never showed up for the follow-up appointment. Of the remaining 11, six infants had normal hearing, three had otitis media with effusion or other conductive HL. The last two infants had HL. Specifically, one had bilateral sensorineural HL greater than 40db, and one had unilateral sensorineural HL greater than 40db. Risk factors were identified in 523 newborns admitted to the unit. The most common risk factors identified were the use of ototoxic drugs, low Apgar scores, and prematurity. Of all the newborns, 491 passed the test the first time, and the rest 32 infants came back 1-2 months after leaving the neonatal unit. All the babies who had failed in the first screening test appeared for the follow-up appointment for the second screening test. Of these, 24 babies passed the test, but eight did not. Of these, four were diagnosed with media otitis with effusion or other conductive HL. Sensorineural HL was identified in the last four babies using ABR tests. In detail, two had unilateral sensorineural HL greater than 40db, while two had bilateral sensorineural HL greater than 40db. Conclusion In conclusion, we found that for the NHS programs to be effective, they must be implemented long-term and have monetary support. Early diagnosis and cochlear implantation are the keys to excellent outcomes. Cooperation between different specialties and a patient-centred approach will help physicians holistically face neonatal HL. Building trust between the parents and doctor is essential for the program's success and reducing the lost-to-follow-up rate. To run a successful program, trained staff, equipment, and financial support are required. However, the gold standards for the success of the program are proper implementation of the program, close follow-up, strict adherence to the guidelines in the neonatal intensive care unit (NICU), and the early detection and diagnosis of HL.
Identifiants
pubmed: 34956791
doi: 10.7759/cureus.19807
pmc: PMC8693701
doi:
Types de publication
Journal Article
Langues
eng
Pagination
e19807Informations de copyright
Copyright © 2021, Kosmidou et al.
Déclaration de conflit d'intérêts
The authors have declared that no competing interests exist.
Références
J Clin Virol. 2006 Feb;35(2):221-5
pubmed: 16384744
BMJ. 2001 Sep 8;323(7312):536-40
pubmed: 11546698
Adv Neonatal Care. 2003 Dec;3(6):308-17
pubmed: 14695502
Laryngoscope. 2008 Jul;118(7):1253-6
pubmed: 18401271
Int J Pediatr Otorhinolaryngol. 2015 May;79(5):635-7
pubmed: 25758196
ASHA. 1994 Dec;36(12):38-41
pubmed: 7818604
Eur Arch Otorhinolaryngol. 2011 Oct;268(10):1399-406
pubmed: 21698417
N Engl J Med. 2006 May 18;354(20):2151-64
pubmed: 16707752
JAMA. 2020 Dec 01;324(21):2195-2205
pubmed: 33258894
Pediatrics. 2007 Oct;120(4):898-921
pubmed: 17908777
Ann Otol Rhinol Laryngol. 1999 Jun;108(6):525-31
pubmed: 10378518
Arch Dis Child Fetal Neonatal Ed. 2004 Sep;89(5):F378-83
pubmed: 15321952
Acta Paediatr. 2007 Aug;96(8):1155-8
pubmed: 17655618
Int J Pediatr Otorhinolaryngol. 2009 Dec;73(12):1691-5
pubmed: 19796829
Clin Exp Otorhinolaryngol. 2021 Feb;14(1):15-28
pubmed: 32646208
Indian J Otolaryngol Head Neck Surg. 2007 Mar;59(1):15-8
pubmed: 23120376
Eur J Pediatr. 2010 Dec;169(12):1453-63
pubmed: 20544359
Int J Pediatr Otorhinolaryngol. 2010 Sep;74(9):999-1002
pubmed: 20554331
PLoS One. 2017 Sep 14;12(9):e0184359
pubmed: 28910311
Int J Pediatr Otorhinolaryngol. 2008 Jun;72(6):807-16
pubmed: 18395270
J Speech Lang Hear Res. 2018 Nov 8;61(11):2827-2832
pubmed: 30458524
Ann Acad Med Singap. 2005 May;34(4):301-6
pubmed: 15937570
N Engl J Med. 2008 Jul 17;359(3):262-73
pubmed: 18635431
Pediatrics. 2001 Mar;107(3):E29
pubmed: 11230610